The Europe Corneal Implants Market would witness market growth of 5.9% CAGR during the forecast period (2023-2029).
Fuchs' dystrophy, a condition more predominant in the older population, is treated through endothelial keratoplasty (EK). The most frequent problem among older people who have undergone cataract surgery is bullous keratopathy. Those patients are advised to undergo an EK surgery. As a result, the increase in the older population will encourage market growth overall. Due to its biocompatibility and affordability, collagen-based artificial corneas are also in higher demand, which has sparked the creation of bio-engineered artificial corneas.
Moreover, the market is expanding as a result of increased R&D activity in this industry. For instance, companies are creating inexpensive and easily implantable artificial corneas. Such implants are predicted to completely and right away restore the vision of people who are corneally blind. In addition, they have been intended to repair scarred, distorted, or opaque corneas. Hence, the technological advancements outlined above are a factor in the increase in demand for corneal implants.
German citizens now have a life expectancy of more than twice what it was at the end of the 19th century. Nowadays, newborn females are predicted to live for 83 years, while boys are predicted to live for 78 years. The population's age distribution reflects changes in demographics. In Germany, approximately 25 percent of the population is currently 60 or older, which is expected to rise. Thus, with the increasing geriatric population, the prevalence of diseases like Fuchs endothelial is also expected to increase as it is most common in older people, thus providing a rise in the adoption of corneal transplants for the treatment of Fuchs endothelial and driving the market growth in the region.
The Germany market dominated the Europe Corneal Implants Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $38.6 million by 2029. The UK market is anticipated to grow at a CAGR of 5% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 6.7% during (2023 - 2029).
Based on Disease Type, the market is segmented into Fuchs' Dystrophy, Keratoconus, Infectious Keratitis and Others. Based on Procedure Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, and Others. Based on End User, the market is segmented into Hospitals, Ophthalmic Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Corneal Implants Market is Projected to reach USD 595.1 Million by 2029, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Presbia PLC, CorNeat Vision Ltd., Alcon, Inc., AJL Opthalmic SA, LinkoCare Life Sciences AB, CorneaGen, DIOPTEX GmbH, Mediphacos Industrias Medicas S.A., EyeYon Medical Ltd., and KeraMed, Inc.
By Disease Type
By Procedure Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
